Emergence and dissemination of monkeypox, an intimidating global public health problem

The monkeypox virus (MPXV) is the cause of a zoonotic infection similar to smallpox. Although it is endemic to Africa, it has recently begun to circulate in other parts of the world. In July 2022, the World Health Organization declared monkeypox an international public health emergency. This review...

Full description

Bibliographic Details
Main Authors: Hasan Ejaz, Kashaf Junaid, Sonia Younas, Abualgasim E. Abdalla, Syed Nasir Abbas Bukhari, Khalid O.A. Abosalif, Naveed Ahmad, Zeeshan Ahmed, Manhal Ahmed Hamza, Naeem Anwar
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Journal of Infection and Public Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S187603412200243X
_version_ 1811208358009503744
author Hasan Ejaz
Kashaf Junaid
Sonia Younas
Abualgasim E. Abdalla
Syed Nasir Abbas Bukhari
Khalid O.A. Abosalif
Naveed Ahmad
Zeeshan Ahmed
Manhal Ahmed Hamza
Naeem Anwar
author_facet Hasan Ejaz
Kashaf Junaid
Sonia Younas
Abualgasim E. Abdalla
Syed Nasir Abbas Bukhari
Khalid O.A. Abosalif
Naveed Ahmad
Zeeshan Ahmed
Manhal Ahmed Hamza
Naeem Anwar
author_sort Hasan Ejaz
collection DOAJ
description The monkeypox virus (MPXV) is the cause of a zoonotic infection similar to smallpox. Although it is endemic to Africa, it has recently begun to circulate in other parts of the world. In July 2022, the World Health Organization declared monkeypox an international public health emergency. This review aims to provide an overview of this neglected zoonotic pathogen. MPXV circulates as two distinct clades, the Central African and West African, with case fatality rates of 10.6% and 3.6%, respectively. The risk of infection is greater for those who work with animals or infected individuals. The virus’ entry into the human body provokes both natural and acquired immunity. Although natural killer cells, CD4 + T cells, and CD8 + T cells play an essential role in eradicating MPXV, there is still a gap in the understanding of the host immune response to the virus. Currently, there are no specific therapeutic guidelines for treating monkeypox; however, some antiviral drugs such as tecovirimat and cidofovir may help to abate the severity of the disease. The use of nonpharmaceutical interventions and immunization can reduce the risk of infection. Increased surveillance and identification of monkeypox cases are crucial to understand the constantly shifting epidemiology of this resurging and intimidating disease. The present review provides a detailed perspective on the emergence and circulation of MPXV in human populations, infection risks, human immune response, disease diagnosis and prevention strategies, and future implications, and highlights the importance of the research community engaging more with this disease for an effective global response.
first_indexed 2024-04-12T04:19:48Z
format Article
id doaj.art-43847b37e4b54be6b54dadc9eeeb4ea9
institution Directory Open Access Journal
issn 1876-0341
language English
last_indexed 2024-04-12T04:19:48Z
publishDate 2022-10-01
publisher Elsevier
record_format Article
series Journal of Infection and Public Health
spelling doaj.art-43847b37e4b54be6b54dadc9eeeb4ea92022-12-22T03:48:15ZengElsevierJournal of Infection and Public Health1876-03412022-10-01151011561165Emergence and dissemination of monkeypox, an intimidating global public health problemHasan Ejaz0Kashaf Junaid1Sonia Younas2Abualgasim E. Abdalla3Syed Nasir Abbas Bukhari4Khalid O.A. Abosalif5Naveed Ahmad6Zeeshan Ahmed7Manhal Ahmed Hamza8Naeem Anwar9Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Al Jouf 72388, Saudi Arabia; Correspondence to: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, P.O. Box 2014, King Khalid Road, Sakaka, Al Jouf, Saudi Arabia.School of Biological and Behavioural Sciences, Queen Mary University of London, E1 4NS London, United KingdomHKU-Pasteur Research Pole, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, ChinaDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Al Jouf 72388, Saudi ArabiaDepartment of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Al Jouf 72388, Saudi ArabiaDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Al Jouf 72388, Saudi ArabiaDepartment of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Al Jouf 72388, Saudi ArabiaInstitute of Industrial Biotechnology, GC University, Lahore 5400, PakistanDepartment of Medical Microbiology, Faculty of Medical Laboratory Sciences, Omdurman Islamic University, Omdurman 14415, SudanAllied Health Department, College of Health and Sport Sciences, University of Bahrain, 32038, Kingdom of BahrainThe monkeypox virus (MPXV) is the cause of a zoonotic infection similar to smallpox. Although it is endemic to Africa, it has recently begun to circulate in other parts of the world. In July 2022, the World Health Organization declared monkeypox an international public health emergency. This review aims to provide an overview of this neglected zoonotic pathogen. MPXV circulates as two distinct clades, the Central African and West African, with case fatality rates of 10.6% and 3.6%, respectively. The risk of infection is greater for those who work with animals or infected individuals. The virus’ entry into the human body provokes both natural and acquired immunity. Although natural killer cells, CD4 + T cells, and CD8 + T cells play an essential role in eradicating MPXV, there is still a gap in the understanding of the host immune response to the virus. Currently, there are no specific therapeutic guidelines for treating monkeypox; however, some antiviral drugs such as tecovirimat and cidofovir may help to abate the severity of the disease. The use of nonpharmaceutical interventions and immunization can reduce the risk of infection. Increased surveillance and identification of monkeypox cases are crucial to understand the constantly shifting epidemiology of this resurging and intimidating disease. The present review provides a detailed perspective on the emergence and circulation of MPXV in human populations, infection risks, human immune response, disease diagnosis and prevention strategies, and future implications, and highlights the importance of the research community engaging more with this disease for an effective global response.http://www.sciencedirect.com/science/article/pii/S187603412200243XOrthopoxvirusesSmallpox virusEpidemiologyImmune evasionDisease outbreaks
spellingShingle Hasan Ejaz
Kashaf Junaid
Sonia Younas
Abualgasim E. Abdalla
Syed Nasir Abbas Bukhari
Khalid O.A. Abosalif
Naveed Ahmad
Zeeshan Ahmed
Manhal Ahmed Hamza
Naeem Anwar
Emergence and dissemination of monkeypox, an intimidating global public health problem
Journal of Infection and Public Health
Orthopoxviruses
Smallpox virus
Epidemiology
Immune evasion
Disease outbreaks
title Emergence and dissemination of monkeypox, an intimidating global public health problem
title_full Emergence and dissemination of monkeypox, an intimidating global public health problem
title_fullStr Emergence and dissemination of monkeypox, an intimidating global public health problem
title_full_unstemmed Emergence and dissemination of monkeypox, an intimidating global public health problem
title_short Emergence and dissemination of monkeypox, an intimidating global public health problem
title_sort emergence and dissemination of monkeypox an intimidating global public health problem
topic Orthopoxviruses
Smallpox virus
Epidemiology
Immune evasion
Disease outbreaks
url http://www.sciencedirect.com/science/article/pii/S187603412200243X
work_keys_str_mv AT hasanejaz emergenceanddisseminationofmonkeypoxanintimidatingglobalpublichealthproblem
AT kashafjunaid emergenceanddisseminationofmonkeypoxanintimidatingglobalpublichealthproblem
AT soniayounas emergenceanddisseminationofmonkeypoxanintimidatingglobalpublichealthproblem
AT abualgasimeabdalla emergenceanddisseminationofmonkeypoxanintimidatingglobalpublichealthproblem
AT syednasirabbasbukhari emergenceanddisseminationofmonkeypoxanintimidatingglobalpublichealthproblem
AT khalidoaabosalif emergenceanddisseminationofmonkeypoxanintimidatingglobalpublichealthproblem
AT naveedahmad emergenceanddisseminationofmonkeypoxanintimidatingglobalpublichealthproblem
AT zeeshanahmed emergenceanddisseminationofmonkeypoxanintimidatingglobalpublichealthproblem
AT manhalahmedhamza emergenceanddisseminationofmonkeypoxanintimidatingglobalpublichealthproblem
AT naeemanwar emergenceanddisseminationofmonkeypoxanintimidatingglobalpublichealthproblem